These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19122267)

  • 1. [New development in bisphosphonate treatment. Review of the preventive effect of minodronic acid on fracture in Japanese patients with osteoporosis].
    Hagino H
    Clin Calcium; 2009 Jan; 19(1):75-84. PubMed ID: 19122267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of minodronic acid hydrate for the treatment of osteoporosis.
    Tanishima S; Morio Y
    Clin Interv Aging; 2013; 8():185-9. PubMed ID: 23440003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study.
    Tanaka S; Yoshida A; Kono S; Ito M
    J Orthop Sci; 2017 May; 22(3):536-541. PubMed ID: 28108224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minodronic acid- its clinical efficacy and prospects for once-a-month dosing regimen].
    Hagino H
    Clin Calcium; 2011 Jan; 21(1):71-6. PubMed ID: 21187597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].
    Leszczyński P
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):168-71. PubMed ID: 21038635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.
    Boonen S; Black DM; Colón-Emeric CS; Eastell R; Magaziner JS; Eriksen EF; Mesenbrink P; Haentjens P; Lyles KW
    J Am Geriatr Soc; 2010 Feb; 58(2):292-9. PubMed ID: 20070415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
    Miki T; Minamide T
    Clin Calcium; 2007 Jan; 17(1):18-22. PubMed ID: 17211089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.
    Matsumoto T; Hagino H; Shiraki M; Fukunaga M; Nakano T; Takaoka K; Morii H; Ohashi Y; Nakamura T
    Osteoporos Int; 2009 Aug; 20(8):1429-37. PubMed ID: 19101754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
    Hagino H
    Clin Calcium; 2011 Nov; 21(11):111-8. PubMed ID: 22040827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis].
    Tanaka M; Mori H; Shimizu K; Toshiyuki ; Matsuoka ; Yamamotoya H; Minamide T; Mori M; Nozaki K; Usui T; Shimokawa K; Suzuki H; Aoyama K; Kimoto A; Sasamata M; Miyata K
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):149-57. PubMed ID: 19749488
    [No Abstract]   [Full Text] [Related]  

  • 12. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
    Black DM; Delmas PD; Eastell R; Reid IR; Boonen S; Cauley JA; Cosman F; Lakatos P; Leung PC; Man Z; Mautalen C; Mesenbrink P; Hu H; Caminis J; Tong K; Rosario-Jansen T; Krasnow J; Hue TF; Sellmeyer D; Eriksen EF; Cummings SR;
    N Engl J Med; 2007 May; 356(18):1809-22. PubMed ID: 17476007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
    Hagino H; Hashimoto J; Okano T; Katagiri H
    Clin Calcium; 2008 Aug; 18(8):1176-82. PubMed ID: 18677057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2014 Mar; 24(3):401-6. PubMed ID: 24576937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of minodronic acid hydrate in patients with steroid-induced osteoporosis.
    Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Ikumi N; Sugiyama K; Nagasawa Y; Karasawa H; Iwata M; Matsukawa Y; Takei M
    Int J Rheum Dis; 2018 Apr; 21(4):813-820. PubMed ID: 26929019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].
    Okazaki R
    Clin Calcium; 2009 Jan; 19(1):30-6. PubMed ID: 19122262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
    Iwamoto J
    Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosis.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Yamada H; Kawada N; Kawabata K
    Calcif Tissue Int; 2014 Aug; 95(2):166-73. PubMed ID: 24903232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid].
    Geusens PP; Lems WF
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1445-8. PubMed ID: 17633971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ibandronate].
    Tobinai M
    Clin Calcium; 2011 Jan; 21(1):79-86. PubMed ID: 21187598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.